RBC Bioscience

RBC Bioscience Market capitalization

The The market capitalization of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 229.80 M TWD. In the previous year, The market capitalization was 229.80 M TWD — a change of 0.00% (lower).

Market capitalization

229.80 MTWD

YoY

0.00%

Last updated:

In 2024, RBC Bioscience's market cap stood at 229.80 M TWD, a 0.00% increase from the 229.80 M TWD market cap in the previous year.

The RBC Bioscience Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
229.80 M TWD
Jan 1, 2019
229.80 M TWD
Jan 1, 2020
229.80 M TWD
Jan 1, 2021
229.80 M TWD
Jan 1, 2022
229.80 M TWD
Jan 1, 2023
229.80 M TWD
Jan 1, 2024
229.80 M TWD
The RBC Bioscience Market capitalization history
YEARMarket capitalizationYoY
229.80 MTWD0.00%
229.80 MTWD0.00%
229.80 MTWD0.00%
229.80 MTWD0.00%
229.80 MTWD0.00%
229.80 MTWD0.00%
229.80 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring RBC Bioscience's Market Capitalization

RBC Bioscience's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of RBC Bioscience's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

RBC Bioscience's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in RBC Bioscience’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about RBC Bioscience stock

The market capitalization of RBC Bioscience is 229.80 M TWD in 2024.

The market capitalization of RBC Bioscience changed from 229.80 M TWD to 229.80 M TWD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's RBC Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — RBC Bioscience

All Key Metrics — RBC Bioscience